{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:36:11Z","timestamp":1757309771754},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s12328-009-0112-x","type":"journal-article","created":{"date-parts":[[2009,10,2]],"date-time":"2009-10-02T07:24:29Z","timestamp":1254468269000},"page":"380-383","source":"Crossref","is-referenced-by-count":11,"title":["Infliximab treatment for Crohn\u2019s disease in a patient with IgA nephropathy"],"prefix":"10.1007","volume":"2","author":[{"given":"Yoshitaka","family":"Ueno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiko","family":"Onitake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Hanaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Chayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,1]]},"reference":[{"key":"112_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00365521.1984.12199901","volume":"95","author":"J Myren","year":"1984","unstructured":"Myren J, Bouchier IA, Watkinson G, Softley A, Clamp SE, de Dombal FT. The O.M.G.E. multinational inflammatory bowel disease survey 1976\u20131982. A further report on 2,657 cases. Scand J Gastroenterol Suppl. 1984;95:1\u201327.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"112_CR2","first-page":"1541","volume":"359","author":"SB Hanauer","year":"2002","unstructured":"Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, et\u00a0al. Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial. N Engl J Med. 2002;359:1541\u20139.","journal-title":"N Engl J Med"},{"key":"112_CR3","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJMoa030815","volume":"350","author":"BE Sands","year":"2004","unstructured":"Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, et\u00a0al. Infliximab maintenance therapy for fistulizing Crohn\u2019s disease. N Engl J Med. 2004;350:876\u201385.","journal-title":"N Engl J Med"},{"key":"112_CR4","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/ibd.20196","volume":"13","author":"A Barrie","year":"2007","unstructured":"Barrie A, Regueiro M. Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:1424\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"112_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0272-6386(12)80550-6","volume":"20","author":"DJ Hirsch","year":"1992","unstructured":"Hirsch DJ, Jindal KK, Trillo A, Cohen AD. Acute renal failure in Crohn\u2019s disease due to IgA nephropathy. Am J Kidney Dis. 1992;20:189\u201390.","journal-title":"Am J Kidney Dis"},{"key":"112_CR6","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/0929-693X(96)87579-8","volume":"3","author":"A Dabadie","year":"1996","unstructured":"Dabadie A, Gie S, Babut JM, Roussey M. IgA nephropathy associated with Crohn disease. Arch Pediatr. 1996;3:884\u20137.","journal-title":"Arch Pediatr"},{"key":"112_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s004670050355","volume":"11","author":"D McCallum","year":"1997","unstructured":"McCallum D, Smith L, Harley F, Yiu V. IgA nephropathy and thin basement membrane disease in association with Crohn\u2019s disease. Pediatr Nephrol. 1997;11:637\u201340.","journal-title":"Pediatr Nephrol"},{"key":"112_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00592-007-0007-6","volume":"44","author":"Y Moriwaki","year":"2007","unstructured":"Moriwaki Y, Inokuchi T, Yamamoto A, Ka T, Tsutsumi Z, Takahashi S, et\u00a0al. Effect of TNF-\u03b1 inhibition on urinary albumin excretion in experimental diabetic rats. Acta Diabetol. 2007;44:215\u20138.","journal-title":"Acta Diabetol"},{"key":"112_CR9","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00467-004-1573-2","volume":"19","author":"D Raveh","year":"2004","unstructured":"Raveh D, Shemesh O, Ashkenazi YJ, Winkler R, Barak V. Tumor necrosis factor-\u03b1 blocking agent as a treatment for nephrotic syndrome. Pediatr Nephrol. 2004;19:1281\u20134.","journal-title":"Pediatr Nephrol"},{"key":"112_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00384-004-0696-z","volume":"20","author":"MJ Forshaw","year":"2005","unstructured":"Forshaw MJ, Guirguis O, Hennigan T. IgA nephropathy in association with Crohn\u2019s disease. Int J Colorectal Dis. 2005;20:463\u20135.","journal-title":"Int J Colorectal Dis"},{"key":"112_CR11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00467-002-0943-x","volume":"17","author":"T Takemura","year":"2002","unstructured":"Takemura T, Okada M, Yagi K, Kuwajima H, Yanagida H. An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications. Pediatr Nephrol. 2002;17:863\u20136.","journal-title":"Pediatr Nephrol"},{"key":"112_CR12","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1007\/s10067-006-0422-z","volume":"26","author":"GT Sakellariou","year":"2007","unstructured":"Sakellariou GT, Vounotrypidis P, Berberidis C. Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy. Clin Rheumatol. 2007;26:1132\u20133.","journal-title":"Clin Rheumatol"},{"key":"112_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1046\/j.1440-1797.2003.00128.x","volume":"8","author":"CS Lim","year":"2003","unstructured":"Lim CS, Yoon HJ, Kim YS, Ahn C, Han JS, Kim S, et\u00a0al. Clinicopathological correlation of intrarenal cytokines and chemokines in IgA nephropathy. Nephrology. 2003;8:21\u20137.","journal-title":"Nephrology"},{"key":"112_CR14","doi-asserted-by":"publisher","first-page":"F945","DOI":"10.1152\/ajprenal.00423.2007","volume":"294","author":"KN Lai","year":"2008","unstructured":"Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW, Lai FM, et\u00a0al. Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy. Am J Physiol Renal Physiol. 2008;294:F945\u201355.","journal-title":"Am J Physiol Renal Physiol"},{"key":"112_CR15","first-page":"277","volume":"20","author":"BA Julian","year":"2000","unstructured":"Julian BA. Treatment of IgA nephropathy. Semin Nephrol. 2000;20:277\u201385.","journal-title":"Semin Nephrol"},{"key":"112_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/00054725-200407000-00024","volume":"10","author":"G D\u2019Haens","year":"2004","unstructured":"D\u2019Haens G. Mucosal healing in pediatric Crohn\u2019s disease: the goal of medical treatment. Inflamm Bowel Dis. 2004;10:479\u201380.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-009-0112-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-009-0112-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-009-0112-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-009-0112-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T22:09:29Z","timestamp":1710626969000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-009-0112-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["112"],"URL":"https:\/\/doi.org\/10.1007\/s12328-009-0112-x","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}